PTAFR antibody (Extracellular) (FITC)
Quick Overview for PTAFR antibody (Extracellular) (FITC) (ABIN7237763)
Target
See all PTAFR AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 259-274, Extracellular
-
Purpose
- A Rabbit Polyclonal Antibody to Platelet-activating factor receptor (extracellular) conjugated to the fluorescent dye FITC
-
Specificity
- Extracellular, 3rd loop.
-
Cross-Reactivity
- Human, Mouse, Rat
-
Predicted Reactivity
- Rat - identical,Human - 13 out of 16 amino acid residues identical
-
Characteristics
- Extracellular, 3rd loop
-
Purification
- Affinity purified on immobilized antigen.
-
Immunogen
-
Immunogen: Synthetic peptide
Immunogen Sequence: (C)ELGYQTNFHQAINDAH, corresponding to amino acid residues 259 - 274 of mouse PTAFR
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Antigen preadsorption control: 1 μg peptide per 1 μg antibody
Application Dilutions Immunohistochemistry paraffin embedded sections ihc: N/A
Application Dilutions Western blot wb: N/A
-
Comment
-
Negative Control: (ABIN7582044)
Blocking Peptide: (ABIN7236256)
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Recosntitute with double distilled water (DDW) to a concentration of 1.0 mg/mL.
-
Concentration
- 1 mg/mL
-
Buffer
- PBS pH 7.4, 1 % BSA with 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.
Storage after reconstitution: The reconstituted solution can be stored at 4°C, protected from the light, for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).
-
-
- PTAFR (Platelet-Activating Factor Receptor (PTAFR))
-
Alternative Name
- PTAFR
-
Background
-
PTAFR, PAFR,Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a biologically active phospholipid mediator that was first described by its ability to cause platelet aggregation and dilation of blood vessels. In addition, PAF acts as a mediator of cell-to-cell communication, inflammation, allergic responses and shock1. PAF acts on PAF receptor (PAFR) a G protein-coupled receptor (GPCR). It consists of 7 transmembrane-spanning domains (TMDs), and two potential N-linked glycosylation sites. PAFR was found to expressed in the lung, neutrophils, monocytes, macrophages, placenta, small intestine, heart, liver, kidney, brain, and spleen. As a results of PAF interaction, PAFR is coupled to Gq protein and consequently activates various downstream signaling pathways2. Experiments in both PAF receptor knockout animals and transgenic animals overexpressing PAF receptors support the pathophysiological role attributed to PAF receptor signaling. For example, Mice model of obstructive nephropathy show that PAFR signaling contributes to a pro-inflammatory environment leading to renal dysfunction and progressive organ failure3. In addition, inhibition of PAFR signaling results in an effective inhibition of experimental tumor growth and metastasis4.
Alternative names: PTAFR, PAFR -
Gene ID
- 19204
-
NCBI Accession
- NM_000952
-
UniProt
- Q62035
-
Pathways
- Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin
Target
-